| Q47354509 | (18)F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings |
| Q88551540 | 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes |
| Q52983682 | 18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis. |
| Q28087002 | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...] |
| Q95282286 | 55-year-old Male with Exertional Dyspnea |
| Q50096284 | A 52-Year-Old Man With Unheralded Syncope |
| Q38732508 | A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis |
| Q64055932 | A Unique Case of Complete Atrioventricular Block Rapidly Progressing to Diastolic and Systolic Dysfunction in Cardiac Sarcoidosis |
| Q39000124 | A complete heart block in a young male: a case report and review of literature of cardiac sarcoidosis |
| Q37017457 | A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis |
| Q47679382 | A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the Ame |
| Q51655005 | A toll-like receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis. |
| Q57621344 | ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures |
| Q40621949 | ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum. |
| Q51422653 | Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach. |
| Q58617082 | Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis |
| Q86793361 | Advanced imaging of cardiac sarcoidosis |
| Q64965888 | Advances in Cardiovascular MRI using Quantitative Tissue Characterisation Techniques: Focus on Myocarditis. |
| Q38574702 | Advances in radionuclide imaging of cardiac sarcoidosis. |
| Q94602106 | Arguable ICD placement in a sarcoidosis patient with extensive cardiac involvement |
| Q92069991 | Artificial Intelligence versus Doctors' Intelligence: A Glance on Machine Learning Benefaction in Electrocardiography |
| Q99581925 | Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis |
| Q28073428 | Atrial Fibrillation in Cardiac Sarcoidosis |
| Q33625524 | Benefit of magnetic resonance-conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis-involved cervical extradural lesion |
| Q54961794 | Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis. |
| Q42322647 | Bidirectional ventricular tachycardia in cardiac sarcoidosis. |
| Q38851511 | Biomarkers in sarcoidosis |
| Q98224788 | Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects |
| Q60950653 | Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis |
| Q97520854 | Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies |
| Q91875383 | Cardiac Sarcoidosis: A Picture May Be Worth a Thousand Words, But Do We Need More? |
| Q36541500 | Cardiac Sarcoidosis: Is it More Common in Men? |
| Q42668972 | Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature. |
| Q38911750 | Cardiac manifestations of sarcoidosis: diagnosis and management |
| Q90290016 | Cardiac sarcoidosis presenting with syncope and rapidly progressive atrioventricular block: a case report |
| Q36249399 | Cardiac sarcoidosis resembling panic disorder: a case report |
| Q58096609 | Cardiac sarcoidosis with complete metabolic response and resolution of left ventricular dysfunction complicated by subsequent VT storm |
| Q26765213 | Cardiac sarcoidosis-state of the art review |
| Q88091299 | Cardiac sarcoidosis: An important niche for PET, but a journey just begun |
| Q38541252 | Cardiac sarcoidosis: diagnosis and management |
| Q47258811 | Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis |
| Q53712556 | Case 1/2018 - Young Male with Heart Disease Expressed Mainly as Ventricular Arrhythmia, Right Ventricular Dysfunction and Syncope. |
| Q91544856 | Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography |
| Q47678958 | Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters |
| Q92756732 | Clinical Features and Histopathology of Cardiac Sarcoidosis with Refractory Heart Failure: An Autopsy Case |
| Q93110882 | Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis |
| Q89184375 | Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation |
| Q38602609 | Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis |
| Q52991023 | Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. |
| Q50043428 | Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. |
| Q53778571 | Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease. |
| Q38432173 | Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence |
| Q38830086 | Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care |
| Q53375412 | Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study. |
| Q37543559 | Development of Evidence-based Recommendations: Implications for Preparing Expert Consensus Statements |
| Q91948784 | Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline |
| Q38661618 | Diagnosis and treatment of cardiac sarcoidosis |
| Q51649385 | Diagnosis of Sarcoidosis. |
| Q96647257 | Diagnosis of isolated cardiac sarcoidosis based on new guidelines |
| Q87156012 | Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET |
| Q94603354 | Diagnostic accuracy of cardiac MRI, FDG-PET, and myocardial biopsy for the diagnosis of cardiac sarcoidosis: a protocol for a systematic review and meta-analysis |
| Q92777544 | Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis |
| Q50074136 | Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications |
| Q90324665 | Editorial: Diagnosis of cardiac sarcoidosis - What is the role of endomyocardial biopsy? |
| Q41196664 | Electrical storm in the inflamed heart: ventricular tachycardia due to myocarditis |
| Q92007977 | Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging |
| Q57173299 | Emerging Tracers for Nuclear Cardiac PET Imaging |
| Q98289853 | Exercise-induced torsades de pointes as an unusual presentation of cardiac sarcoidosis: A case report and review of literature |
| Q98292368 | Extrapulmonary Involvement in Sarcoidosis: A Case Report |
| Q93052661 | Fabry Disease with Pacemaker Implantation as the Initial Event |
| Q97520880 | Fluorodeoxyglucose Applications in Cardiac PET: Viability, Inflammation, Infection, and Beyond |
| Q51024650 | Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy. |
| Q39008785 | Fulminant isolated cardiac sarcoidosis with pericardial effusion and acute heart failure: Challenging aspects of diagnosis and treatment |
| Q90056443 | Giant Cell Myocarditis: A Time Sensitive Distant Diagnosis |
| Q38920755 | Heart Rhythm Society: expert consensus statements-part 1. |
| Q93120436 | Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology |
| Q92277174 | Hidden in Heart Failure |
| Q47712616 | High-Risk Sarcoidosis. Current Concepts and Research Imperatives |
| Q47649571 | Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States |
| Q47719399 | Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. |
| Q39413687 | Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series |
| Q41100686 | Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. |
| Q99240135 | Incessant PVCs and Cardiomyopathy: Think Outside the Box |
| Q26798533 | Infiltrative Cardiomyopathies |
| Q90112809 | Inflammasome Formation in Granulomas in Cardiac Sarcoidosis |
| Q36794947 | Insights into biopsy-proven cardiac sarcoidosis in patients with heart failure. |
| Q38950670 | Isolated cardiac sarcoidosis: A focused review of an under-recognized entity |
| Q54644191 | Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. |
| Q88668462 | Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring |
| Q35245427 | Left ventricular aneurysm and ventricular tachycardia as initial presentation of cardiac sarcoidosis |
| Q90187991 | Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis |
| Q65001472 | Lyme disease and cardiac sarcoidosis: Management of associated ventricular arrhythmias. |
| Q64239218 | Lymph Vessel Proliferation on Cardiac Biopsy May Help in the Diagnosis of Cardiac Sarcoidosis |
| Q36956707 | Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis |
| Q58583656 | Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres |
| Q61818193 | Management of Arrhythmias Associated with Cardiac Sarcoidosis |
| Q26801775 | Management of Arrhythmias in Cardiac Sarcoidosis |
| Q47217272 | Management of Bradyarrhythmias in Heart Failure: A Tailored Approach |
| Q52642707 | Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. |
| Q38919543 | Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients |
| Q92378330 | Molecular Imaging of the Heart |
| Q90653351 | Multimodality Imaging to Diagnose Isolated Cardiac Sarcoidosis and Determine Regional Inflammatory Activity Levels |
| Q58565267 | Multimodality imaging, electrophysiologic, electroanatomic, and histopathologic characterization of atrial sarcoidosis presenting with sinus arrest and reentrant right atrial flutter |
| Q37556074 | Myocardial Immunocompetent Cells and Macrophage Phenotypes as Histopathological Surrogates for Diagnosis of Cardiac Sarcoidosis in Japanese |
| Q64915439 | Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases. |
| Q89691401 | Myocardial Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis: Specialized Protocols for Better Diagnosis |
| Q47956452 | Myocardial contractile patterns predict future cardiac events in sarcoidosis |
| Q100526188 | Myocarditis and inflammatory cardiomyopathy: current evidence and future directions |
| Q85895034 | Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis |
| Q51060184 | Outcome of Patients With Cardiac Sarcoidosis Who Received Cardiac Resynchronization Therapy: Comparison With Dilated Cardiomyopathy Patients. |
| Q38353696 | Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator |
| Q89972933 | Outflow-tract ventricular tachycardia: Can 12 lead ECG during sinus rhythm identify underlying cardiac sarcoidosis? |
| Q41197657 | Palpitations as a presenting feature of multisystem sarcoidosis |
| Q33165334 | Pathophysiology and clinical management of cardiac sarcoidosis. |
| Q52822379 | Patient page-sarcoidosis imaging. |
| Q51834996 | Predictors and Therapy of Cardiomyopathy Caused by Frequent Ventricular Ectopy. |
| Q30245404 | Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis |
| Q37176025 | Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests |
| Q37683579 | Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis |
| Q85639989 | Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD : 4. Novel applications of cardiovascular PET |
| Q36477873 | Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance. |
| Q30276294 | Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis |
| Q51730534 | Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia. |
| Q26748574 | Pulmonary hypertension complicating pulmonary sarcoidosis |
| Q38829878 | Recent Advances in Nuclear Cardiology |
| Q41528372 | Recent Advances in Understanding and Managing Cardiomyopathy. |
| Q49267631 | Recovery of High Degree Atrioventricular Block in a Patient with Cardiac Sarcoidosis by Corticosteroid Therapy |
| Q92157769 | Recurrent polymorphic ventricular tachycardia initiated by Purkinje ectopy in a patient with cardiac sarcoidosis |
| Q64118092 | Remaining challenges in the diagnosis of early stage cardiac sarcoidosis |
| Q47757667 | Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis |
| Q92157805 | Resolution of new left bundle branch block and ventricular tachycardia with immunosuppressive therapy in a patient with cardiac sarcoidosis |
| Q45008035 | Response to letter "evaluation of cardiac involvement in caucasian patients with skin sarcoidosis". |
| Q47756850 | Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. |
| Q46775971 | Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance |
| Q47936384 | Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease. |
| Q38742921 | Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. |
| Q91920988 | Risk stratification in cardiac sarcoidosis: The tricky business of predicting the future |
| Q45069359 | Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy |
| Q39114674 | Role of Imaging in Evaluating Infiltrative Heart Disease. |
| Q28069234 | Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology |
| Q88737195 | Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis |
| Q38718871 | Sarcoidosis of the cardio-pulmonary systems. |
| Q54150157 | Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population. |
| Q41452186 | Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis |
| Q37718443 | Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. |
| Q56764232 | Somatostatin receptor based hybrid imaging in sarcoidosis |
| Q39388903 | Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications |
| Q39410638 | Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment. |
| Q55712134 | Syncope on exertion in a young male. |
| Q48249573 | Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis. |
| Q38255985 | The Clinical Features of Sarcoidosis: A Comprehensive Review |
| Q36670175 | The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement |
| Q91535291 | The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy |
| Q39560584 | The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. |
| Q39548660 | The role of nuclear cardiac imaging in risk stratification of sudden cardiac death |
| Q97645768 | The use of cardiovascular magnetic resonance for the assessment of left ventricular hypertrophy |
| Q89985432 | The use of serial cardiac 18F-fluorodeoxyglucose- positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review |
| Q38802904 | Update on Treatment in Cardiac Sarcoidosis |
| Q92036760 | Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy |
| Q51115479 | Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction. |
| Q91135729 | Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines |
| Q48507998 | What is the evidence? A call for scientific rigor : Fourteenth Annual Mario S. Verani, MD, Memorial Lecture |
| Q87741583 | What is this image? 2016: Image 1 Result |
| Q52985921 | [Many faces of sarcoidosis]. |
| Q94088804 | “Eyeing” the Cause of Heart Failure: Visible Telltale Clues |